• Epacadostat (INCB024360): IDO1 Evidence

  2026-10-10

  Epacadostat (INCB024360) is a vendor-described oral IDO1 inhibitor used to study tryptophan-catabolism and tumor-immune interactions. Its biochemical potency supports mechanistic research, but clinical evidence shows that PD-1/PD-L1 checkpoint inhibitor combination therapy did not improve progression-free survival in a phase 3 melanoma trial.

• AZD1390, ATM Signaling, and G-Quadruplex Stress

  2026-10-09

  This overview examines how the 2026 REV1–DHX36 study informs conceptual research on AZD1390, an ATM kinase inhibitor. It separates published mechanistic findings from supplier-reported pharmacology and outlines evidence strength, possible research questions, and important limits on interpretation.

• Caspase-8 Assays: Evidence, Meaning and Limits

  2026-10-09

  A source-grounded overview of what IETD-dependent fluorescence can measure, how the 2024 hyperthermia–cisplatin study supports a caspase-8 mechanism, and why assay signals should not be treated as standalone proof of apoptosis, pyroptosis, or clinical relevance.

• Angiotensin Peptides and SARS-CoV-2 Spike Binding

  2026-10-08

  Oliveira and colleagues reported that several naturally occurring angiotensin peptides enhance binding between SARS-CoV-2 spike protein and host receptors, with receptor- and sequence-dependent effects. The findings expand renin-angiotensin system research into viral-entry biology while remaining limited to biochemical binding evidence rather than demonstrated changes in infection or clinical disease.

• hiPSC Intestinal Organoids for Pharmacokinetic Studies

  2026-10-08

  Saito and colleagues report a direct three-dimensional culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. The resulting organoids can be maintained, cryopreserved, and differentiated into intestinal epithelial cells with enterocyte-associated CYP and transporter activities, supporting more human-relevant in vitro pharmacokinetic research.

• DHE ROS Assay: Evidence, Meaning and Limits

  2026-10-07

  A source-grounded guide to what DHE fluorescence can show, how it relates to DON-induced inflammation, and why the evidence does not establish a universal ROS measure or clinical conclusion.

• Anlotinib Hydrochloride in Angiogenesis Research

  2026-10-07

  A source-grounded overview of anlotinib hydrochloride in preclinical angiogenesis research, covering VEGFR2 biology, endothelial assays, tumor models, evidence comparisons, translational applications, and important limitations.

• Deferiprone and Iron-Linked Kidney Injury Research

  2026-10-06

  A source-grounded overview of Deferiprone as an iron-modulating research tool, centered on a 2026 sickle cell mouse study linking renal iron accumulation with lipid peroxidation and acute kidney injury. The evidence supports a mechanistic hypothesis, but does not establish human efficacy or justify extrapolation to cancer, neurovascular disease, or routine treatment.

• YTHDF2, m6A, and Hippocampal Memory

  2026-10-06

  A 2025 Advanced Science study links YTHDF2-mediated degradation of m6A-modified mRNAs to hippocampal synaptic transmission, activity-dependent protein synthesis, and memory. Using forebrain-specific genetic loss and rescue-oriented perturbations, the work positions mRNA decay—not only m6A deposition or removal—as a mechanistic regulator of neural plasticity.

• Gastrin I: Interpreting GI Organoid Evidence

  2026-10-05

  Gastrin I can clarify CCK2 receptor biology, but its interpretation in intestinal organoids requires careful separation of gastric acid secretion from intestinal pharmacokinetics. This evidence-focused guide connects human Gastrin I peptide research with the findings and limitations of hiPSC-derived intestinal organoid models.

• Triiodothyronine (T3): Research Context and Evidence

  2026-10-05

  Triiodothyronine is a biologically active thyroid hormone used as a research perturbation for studying receptor-mediated gene regulation, metabolism, growth, and development. This overview separates vendor-described product attributes from peer-reviewed evidence, explains conceptual applications in cellular metabolism assays and metabolic disorder research, and clarifies why findings from a recent oligodendrocyte gene-editing study should not be extrapolated to T3 biology.

• ATRX-Deficient Glioma Sensitivity to PDGFR Inhibitors

  2026-10-04

  The 2022 Cancers study by Pladevall-Morera and colleagues identifies ATRX deficiency as a context associated with greater sensitivity to selected receptor tyrosine kinase and PDGFR inhibitors in high-grade glioma cells. Its combination findings with temozolomide support ATRX-aware interpretation of targeted-therapy studies, while remaining primarily preclinical and cellular evidence.

• SEMA3E, Beige Fat, and β-Catenin Signaling

  2026-10-03

  A 2026 mouse study identifies SEMA3E as a regulator of beige adipocyte differentiation and non-shivering thermogenesis, linking its activity to mitochondrial respiration and Wnt/β-catenin signaling. The findings strengthen a mechanistic model of adipose tissue remodeling, while remaining primarily preclinical and requiring validation across species and disease contexts.

• Cediranib (AZD2171): Measure the Mechanism

  2026-10-02

  Cediranib (AZD2171) is more than an angiogenesis inhibitor: it is a practical probe for separating VEGFR signaling pathway suppression, growth inhibition, and cell death. This thought-leadership guide connects mechanism, assay design, and translational decision-making for cancer research.

• CAF Lactate, ANTXR1 Lactylation, and Oxaliplatin Resistance

  2026-10-01

  A 2025 Cancer Letters study identifies a CAF-to-colorectal cancer lactate circuit that links stromal glycolysis to ANTXR1 lactylation, cancer stemness, and oxaliplatin resistance. Its cell and xenograft evidence supports targeting the lactate shuttle as a strategy to improve chemotherapy response, while also highlighting the need for clinical validation of ANTXR1-related biomarkers.

8477 records 1/566 page Next 12345 下5页 Last page